We monitored, to our knowledge for the first time, VEGFR2-positive circulating endothelial cells and CD133-positive haematopoietic progenitor cells in NSCLC patients treated with the anti-angiogenic agent SO combined with ER. Here, PROM1 is linked to non-small cell lung carcinoma.